Monday, May 9, 2022

AskGene Limited Raises $20M

Camarillo, California and Nanjing, China-based AskGene Limited, a startup biopharmaceuticals company, said today that it has raised $20M in a Series A financing round. The funding was led by Qiming Venture Partners and TF Capital. According to the company, it is working on cytokines for immunotherapy. AskGene is led by CEO Jeff Lu. The company said the funds will go to advance clinical development of its pipeline. More information »